Your session is about to expire
← Back to Search
Sedation-Epidural vs Spinal Anesthesia for Hip and Knee Surgery (RCT SEA vs SA Trial)
N/A
Recruiting
Led By Mina Morcos, Dr
Research Sponsored by Maisonneuve-Rosemont Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 3
Awards & highlights
No Placebo-Only Group
Summary
"This trial aims to compare the effectiveness of two different nerve block techniques in reducing postoperative complications like pain, low blood pressure, urine retention, and prolonged motor block after hip or knee replacement surgery. The
Who is the study for?
This trial is for adults needing outpatient hip or knee surgery who can safely receive anesthesia. It's not suitable for those with specific health conditions that could interfere with the study, allergies to anesthetics, or a history of substance abuse affecting pain perception.
What is being tested?
The study compares two types of numbing methods during surgery: spinal anesthesia and sedation-epidural anesthesia. The goal is to see which one leads to fewer complications like pain, low blood pressure, inability to urinate, and muscle weakness after surgery.
What are the potential side effects?
Possible side effects include discomfort at the injection site, headache, backache, nausea, difficulty urinating and in rare cases nerve damage. Both techniques may also cause low blood pressure or slow breathing if medication spreads too far.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 3
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 3
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Adverse Events
Secondary study objectives
Adverse event
Complications related to the technique performed.
Conversion to GA
+14 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: SAActive Control1 Intervention
SA will be performed in the sitting or lateral position under sterile conditions. Spinal puncture will be performed at L2-L4 level using 50 mg of Clorotekal 1 or 2%. (intermediate-acting amide local anesthesia, commonly used) will be injected (32-34)
Group II: SED-EAActive Control1 Intervention
EA will be performed in the sitting or lateral position under sterile conditions. Epidural puncture will be performed at the L2-L4 level and an epidural catheter will be inserted into the epidural space. 10 ml of 2% xylocaine without epinephrine will be injected through the catheter and the dose will be titrated (up to 20 mL) to achieve complete sensory block up to T12 dermatoma measured with a level to ice.
Find a Location
Who is running the clinical trial?
Pierre DroletUNKNOWN
Mina Wahba MorcosUNKNOWN
Maisonneuve-Rosemont HospitalLead Sponsor
101 Previous Clinical Trials
38,195 Total Patients Enrolled
Ariane ClairouxUNKNOWN
Veronique BrulotteUNKNOWN
Philippe RichebéUNKNOWN
Marie-Eve BélangerUNKNOWN
Issam TanoubiUNKNOWN
2 Previous Clinical Trials
53 Total Patients Enrolled
Karina PelleiUNKNOWN
Mina Morcos, DrPrincipal InvestigatorCiusss de L'Est de l'Île de Montréal